Fidelta: Galapagos NV: Selvita completes acquisition of Fidelta from Galapagos
Mechelen, Belgium and Krakow, Poland - 04 January 2021, 22.01 TIME CET - Galapagos NV (Euronext & NASDAQ: GLPG) and Selvita S.A. (WSE: SLV) announced today that the strategic transaction in which S...
Read full article »
Fidelta is a contract research organization that provides drug discovery and development services for the pharmaceutical industry.
Read more